Syros Pharmaceuticals, Inc. engages in the development of gene control therapies for cancer and diseases. Its product candidates include SY-1425, SY-2101, and SY-5609. The company was founded by Richard A. Young, Nathanael S. Gray, and James E. Bradner on November 9, 2011 and is headquartered in Cambridge, MA.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
N/A
Frequently Asked Questions
What is Market Cap of Syros Pharmaceuticals Inc.?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Syros Pharmaceuticals Inc. market cap is $21,466.00.
What is the 52-week high for Syros Pharmaceuticals Inc.?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Syros Pharmaceuticals Inc. 52 week high is $0.2969 as of January 09, 2026.
What is the 52-week low for Syros Pharmaceuticals Inc.?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Syros Pharmaceuticals Inc. 52 week low is $0.0001 as of January 09, 2026.
What is Syros Pharmaceuticals Inc. stock price today?
Syros Pharmaceuticals Inc. stock price today is $0.0002.
What was Syros Pharmaceuticals Inc. stock price yesterday?
Syros Pharmaceuticals Inc. stock price yesterday was $0.0008.
What is the 50-day moving average of Syros Pharmaceuticals Inc.?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Syros Pharmaceuticals Inc. 50-day moving average is $0.0005.